Description
Mubritinib is an EGFR2 (HER2) inhibitor that underwent clinical trials, showing some promise as an anticancer chemotherapeutic in the treatment of bladder, kidney, and prostate cancer, but was not pursued further.
Product Unit Size | Cost | Quantity | Stock |
---|
Mubritinib is an EGFR2 (HER2) inhibitor that underwent clinical trials, showing some promise as an anticancer chemotherapeutic in the treatment of bladder, kidney, and prostate cancer, but was not pursued further.
Cas No. | 366017-09-6 |
---|---|
Purity | ≥99% |
Formula | C25H23F3N4O2 |
Formula Wt. | 468.47 |
Chemical Name | 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole |
IUPAC Name | 4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4- (trifluoromethyl)phenyl]ethenyl]-1,3-oxazole |
Synonym | TAK-165 |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Nagasawa J, Mizokami A, Koshida K, et al. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo. Int J Urol. 2006 May;13(5):587-92. PMID: 16771730.
Vitamin E analog, antioxidant.
Paclitaxel derivative
TGFbeta receptor inhibitor
Mycotoxin contaminant found in cereal grains.
Prolyl hydroxylase inhibitor.
Found in Discodermia; PP1 and PP2A inhibitor.
Salicylic acid prodrug, NSAID; weak COX-1/2 inh...
PORCN inhibitor.
mTOR activator.
Polyanionic sulfated glycosaminoglycan, endogen...
Organosulfur found in Allium; analog of alliin....
Prodrug of the compound mycophenolic acid.
5-HT1A agonist, α1-adrenergic antagonist.
Sulforaphane homolog, ITC found in cruciferous ...
Triterpenoid
Endogenous peptide fragment, involved in vasoco...
β2-adrenergic agonist.
Synthetic cytokinin, plant growth regulator; fi...
Steroidal saponin found in Tribulus, Trigonella...
Endogenous neuropeptide, involved in opioid sig...